ALDH1A2 and prostate carcinoma: Regarding ALDH1A2, another protective biomarker in our study, it has been reported that the promoter region was significantly hypermethylated in prostate cancer, and overexpression of ALDH1A2 resulted in decreased colony growth, suggesting that ALDH1A2 serves as a tumor suppressor in prostate cancer [37].